RANI Stock Price
Rani Therapeutics Holdings, Inc.
RANI stock price is $0.67 (-8.59% on the day), giving Rani Therapeutics Holdings, Inc. a market cap of $93.42M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
RANI Stock Overview
- Price
- $0.67
- Previous close
- $0.73
- Open
- $0.71
- Market cap
- $93.42M
- P/E ratio
- -3.1
- 52-week range
- $0.45 - $3.87
- 1-year price target
- $7.17
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 32
About Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RANI | $0.67 | -8.6% | 1.20M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rani Therapeutics Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW